Research ArticleClinical Studies

Kinetics of HER2/neu ECD in 45 Patients Treated with Trastuzumab (Herceptin®) between January 2001 and June 2005 at the Grenoble University Hospital

ANNE-SOPHIE GAUCHEZ, MARC COLONNA, FRANÇOIS-XAVIER BRAND, NADIA RAVANEL, DOMINIQUE PASQUIER, RAOUL PAYAN and MIREILLE MOUSSEAU
Anticancer Research May 2009, 29 (5) 1703-1707;

Article Information

vol. 29 no. 5 1703-1707
PMID 
19443390
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received August 22, 2008
  • Revision received December 6, 2008
  • Accepted January 19, 2009
  • Published online May 13, 2009.
Copyright & Usage 
Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. ANNE-SOPHIE GAUCHEZ1,5,
  2. MARC COLONNA2,
  3. FRANÇOIS-XAVIER BRAND1,
  4. NADIA RAVANEL1,
  5. DOMINIQUE PASQUIER1,
  6. RAOUL PAYAN3 and
  7. MIREILLE MOUSSEAU4,5
  1. 1Biology Department, Grenoble University Hospital
  2. 2Isère Cancer Registry, Meylan
  3. 3Belledonne Clinical Center, Saint Martin d'Hères
  4. 4Oncology Department, Grenoble University Hospital
  5. 5INSERM U 877, University of Grenoble, Grenoble, France
  1. Correspondence to: Anne-Sophie Gauchez, Biology Department, Grenoble University Hospital 38043 Grenoble cedex 9, France. Tel: +33 476765607, Fax: +33 476765181 e-mail: ASGauchez{at}chu-grenoble.fr
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Kinetics of HER2/neu ECD in 45 Patients Treated with Trastuzumab (Herceptin®) between January 2001 and June 2005 at the Grenoble University Hospital
ANNE-SOPHIE GAUCHEZ, MARC COLONNA, FRANÇOIS-XAVIER BRAND, NADIA RAVANEL, DOMINIQUE PASQUIER, RAOUL PAYAN, MIREILLE MOUSSEAU
Anticancer Research May 2009, 29 (5) 1703-1707;
Twitter logo Facebook logo Mendeley logo

Jump to section